Literature DB >> 2642522

Monoclonal antibodies to Pneumocystis carinii: identification of specific antigens and characterization of antigenic differences between rat and human isolates.

J A Kovacs1, J L Halpern, B Lundgren, J C Swan, J E Parrillo, H Masur.   

Abstract

To increase understanding of the antigenic structure of Pneumocystis carinii, we developed monoclonal antibodies to rat and human P. carinii. The specificity of the antibodies was demonstrated by immunofluorescence and immunoblot studies. Only one of five monoclonal antibodies to rat P. carinii reacted with human P. carinii, and none of four monoclonal antibodies to human P. carinii reacted with rat P. carinii. Two antibodies to human P. carinii reacted by immunofluorescence with only one human P. carinii isolate. Immunoblot studies identified major antigens of rat P. carinii with molecular masses of 40,000-100,000 daltons and of human P. carinii with molecular masses of 22,000-95,000 daltons. These studies document the existence of antigenic differences between rat and human P. carinii and are consistent with the suggestion that individual isolates of human P. carinii are also antigenically different. Further studies with these antibodies should increase understanding of the antigenic nature of P. carinii and of the interaction of P. carinii with its host.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642522     DOI: 10.1093/infdis/159.1.60

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  42 in total

Review 1.  Pneumocystis.

Authors:  Francis Gigliotti; Andrew H Limper; Terry Wright
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  Monoclonal immunofluorescence compared with silver stain for investigating Pneumocystis carinii pneumonia.

Authors:  J Midgley; P A Parsons; D C Shanson; O A Husain; N Francis
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

3.  Gene arrays at Pneumocystis carinii telomeres.

Authors:  Scott P Keely; Hubert Renauld; Ann E Wakefield; Melanie T Cushion; A George Smulian; Nigel Fosker; Audrey Fraser; David Harris; Lee Murphy; Claire Price; Michael A Quail; Kathy Seeger; Sarah Sharp; Carolyn J Tindal; Tim Warren; Eduard Zuiderwijk; Barclay G Barrell; James R Stringer; Neil Hall
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

Review 4.  Pneumocystis carinii pneumonia after 40 years.

Authors:  M Nouza
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

5.  Characterization of major surface glycoprotein genes of human Pneumocystis carinii and high-level expression of a conserved region.

Authors:  Q Mei; R E Turner; V Sorial; D Klivington; C W Angus; J A Kovacs
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Nucleotide sequence variation in Pneumocystis carinii strains that infect humans.

Authors:  C H Lee; J J Lu; M S Bartlett; M M Durkin; T H Liu; J Wang; B Jiang; J W Smith
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

7.  Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen.

Authors:  S A Theus; D W Sullivan; P D Walzer; A G Smulian
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Characterization of multiple unique cDNAs encoding the major surface glycoprotein of rat-derived Pneumocystis carinii.

Authors:  M J Linke; A G Smulian; J R Stringer; P D Walzer
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

9.  Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.

Authors:  C J Boylan; W L Current
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Isolation and characterization of a recombinant antigen of Pneumocystis carinii.

Authors:  A G Smulian; J R Stringer; M J Linke; P D Walzer
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.